Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 20/20 | 0.76 |
| ▸ | PTGDR | Q13258 | 2/20 | 0.76 |
| ▸ | PTGIR | P43119 | 1/20 | 0.76 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Timapiprant SCHEMBL29379400 | 0.86 | PTGDR2 (1.00) | PTGDR2PTGDRPTGIRCYP1A2CYP3A4 | |
| Timapiprant SCHEMBL29648518 | 0.86 | PTGDR2 (1.00) | PTGDR2PTGDRPTGIRCYP1A2CYP3A4 | |
| Timapiprant SCHEMBL1782956 | 0.86 | PTGDR2 (1.00) | PTGDR2PTGDRPTGIRCYP1A2CYP3A4 | |
| SCHEMBL1786306 | 0.80 | PTGDR2 (0.73) | PTGDR2PTGDRPTGIRCYP1A2CYP3A4 | |
| SCHEMBL1782585 | 0.79 | PTGDR2 (0.72) | PTGDR2PTGDRPTGIRCYP1A2CYP3A4 | |
| SCHEMBL1786702 | 0.78 | PTGDR2 (0.85) | PTGDR2PTGDRPTGIRCYP1A2CYP3A4 | |
| SCHEMBL16558834 | 0.77 | PTGDR2 (0.82) | PTGDR2PTGDRPTGIRCYP1A2CYP3A4 | |
| SCHEMBL15016329 | 0.77 | PTGDR2 (0.78) | PTGDR2PTGDRPTGIRCYP1A2CYP3A4 | |
| SCHEMBL22167497 | 0.76 | PTGDR2 (0.80) | PTGDR2PTGDRPTGIRCYP1A2CYP3A4 | |
| SCHEMBL18456932 | 0.76 | PTGDR2 (0.81) | PTGDR2PTGDRPTGIR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2697215-A1 | AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL)-ACETIC ACID | Atopix Therapeutics Limited (GB) | 2014-02-19 | — | — | EP | disclosed |
| WO-2012119841-A1 | AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL)-ACETIC ACID | OXAGEN LIMITED (GB) | 2012-09-13 | — | — | WO | disclosed |
| EP-1856094-A1 | MICROCRYSTALLINE (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL)ACETIC ACID | Oxagen Limited (GB) | 2007-11-21 | — | — | EP | disclosed |
| WO-2006092579-A1 | MICROCRYSTALLINE ( 5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL) ACETIC ACID | OXAGEN LIMITED (GB) | 2006-09-08 | — | — | WO | disclosed |